ÂÜÀòÂÒÂ×

Oliver Horlacher is an accomplished professional in AI and data science, currently serving as the Director of AI and Data Science at Orbis Medicines since December 2023. With a career spanning over two decades, Oliver has held significant roles including Director and Software Engineer at Cytocode Limited since 2010, and Associate Director of AI and Data Science as well as Senior Bioinformatics Data Scientist at Ridgeline Therapeutics from April 2019 to December 2023. Previous experience also includes positions at Bruker BioSpin, SIB Swiss Institute of Bioinformatics, and several contract roles that highlight expertise in bioinformatics software engineering. Oliver holds a PhD in Bioinformatics from the University of Geneva and multiple degrees from The University of Auckland, demonstrating a strong academic foundation in biological sciences and computer science.